Table 1 Clinicopathological characteristics of the enrolled gastric cancer patients
Clinicopathological characteristic | N(%) |
|---|---|
Gender | |
 Male | 128 (74.9) |
 Female | 43 (25.1) |
Age (yr) | |
 <65 | 135 (78.9) |
 ≥65 | 36 (21.1) |
Tumor location | |
 Lower third | 89 (52.0) |
 Middle third | 41 (24.0) |
 UGEJ | 31 (18.1) |
 Diffuse | 10 (5.8) |
Tumour size (cm) | |
 <5 | 65 (38.0) |
 ≥5 | 106 (62.0) |
ypT Stage | |
 0–2 | 39 (22.8) |
 3–4 | 132 (77.2) |
ypN Stage | |
 0 | 63 (36.8) |
 1 | 31 (18.1) |
 2 | 29 (17.0) |
 3 | 48 (28.1) |
ypTNM Stage | |
 I | 32 (18.7) |
 II | 43 (25.1) |
 III | 96 (56.1) |
Histological types | |
 Non-low-adherent adenocarcinoman | 106 (62.0) |
 Low-adhesion adenocarcinoma | 65 (38.0) |
Lauren classification | |
 Intestinal | 89 (52.0) |
 Diffuse or Mixed | 82 (48.0) |
Degree of differentiation | |
 Well | 34 (19.9) |
 Moderate or Poor | 137 (80.1) |
Vascular or lymphatic invasion | |
 No | 132 (77.2) |
 Yes | 39 (22.8) |
Nerve invasion | |
 No | 135 (78.9) |
 Yes | 36 (21.1) |
Mandard TRG | |
 1–2 | 58 (33.9) |
 3–5 | 113 (66.1) |